Acute respiratory distress syndrome (ARDS)

The safety and efficacy profile of MSCs differ depending on cell source, manufacturing protocols, administration procedures, biology of disease to be treated and the biology of each individual patient.

StromaBio´s MSC product are isolated from bone marrow of healthy donors. Isolated cells are expanded in the laboratory under strict sterile conditions and tested for purity and functionality before being released, following the legislation for manufacturing of sterile advanced medicinal products.The product is manufactured in Sweden. The MSC product is administered in the ideal way depending on indication.

Alzheimer’s disease

Neurodegenerative diseases are a group of diverse conditions that are characterized by dysfunction and ongoing loss of neurons and glial cells in the central nervous system (brain and spinal cord). The conditions affect memory, thinking and the ability to perform daily activities.

According to the WHO more than 55 million people live with dementia and each year nearly 10 million new cases are diagnosed. Alzheimer’s Disease (AD) is the most common form of dementia and contributes to 60-70% of cases. Currently there is no cure for AD but multiple drugs are under development. StromaBio will target the inflammatory component of the disease.